Phosphatidylinositol 3′-Kinase/AKT Signaling Is Activated in Medulloblastoma Cell Proliferation and Is Associated with Reduced Expression of PTEN

• Published in: Clinical cancer research Vol. 12; no. 10; pp. 3019 - 3027
• Main Authors: Hartmann, Wolfgang, Digon-Söntgerath, Boris, Koch, Arend, Waha, Anke, Endl, Elmar, Dani, Indra, Denkhaus, Dorota, Goodyer, Cynthia G., Sörensen, Niels, Wiestler, Otmar D., Pietsch, Torsten
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 15.05.2006
• Subjects: Adult; AKT; Antineoplastic agents; Biological and medical sciences; Cell Proliferation; Cerebellar Neoplasms - genetics; Cerebellar Neoplasms - metabolism; Child; childhood tumors; DNA Mutational Analysis; Humans; Immunohistochemistry; Loss of Heterozygosity; Medical sciences; Medulloblastoma - genetics; Medulloblastoma - metabolism; methylation; Neurology; Pharmacology. Drug treatments; Phosphatidylinositol 3-Kinases - metabolism; PI3K; PNET; Polymerase Chain Reaction; Polymorphism, Genetic; Proto-Oncogene Proteins c-akt - metabolism; PTEN; PTEN Phosphohydrolase - biosynthesis; PTEN Phosphohydrolase - genetics; Signal Transduction; Tumor Cells, Cultured; Tumors of the nervous system. Phacomatoses; Cell proliferation; Signal transduction; Enzyme; Transferases; Medulloblastoma; Akt protein kinase; PTEN Gene; Gene expression; 1-Phosphatidylinositol 3-kinase; Tumor suppressor gene
• ISSN: 1078-0432; 1557-3265
• DOI: 10.1158/1078-0432.CCR-05-2187

Purpose: Medulloblastomas represent the most frequent malignant brain tumors of childhood. They are supposed to originate from cerebellar neural precursor cells. Recently, it has been shown that Sonic Hedgehog–induced formation of medulloblastoma in an animal model is significantly enhanced by activation of the phosphatidylinositol 3′-kinase (PI3K) signaling pathway. Experimental Design: To examine a role for PI3K/AKT signaling in the molecular pathogenesis of human medulloblastoma, we did an immunohistochemical study of the expression of Ser 473 -phosphorylated (p)-AKT protein in 22 medulloblastoma samples: All samples displayed p-AKT expression. To investigate if an activated PI3K/AKT pathway is required for medulloblastoma cell growth, we treated five human medulloblastoma cell lines with increasing concentrations of the PI3K inhibitor LY294002 and analyzed cellular proliferation and apoptosis. The antiproliferative effect could be antagonized by overexpressing constitutively active AKT. As the activation of PI3K/AKT signaling may be associated with alterations of the PTEN gene located at 10q23.3, a chromosomal region subject to frequent allelic losses in medulloblastoma, we screened PTEN for mutations and mRNA expression. Results: Proliferation of all of the medulloblastoma cell lines was dependent on PI3K/AKT signaling, whereas apoptosis was not prominently affected. Allelic loss was detected in 16% of the cases. One medulloblastoma cell line was found to carry a truncating mutation in the PTEN coding sequence. Even more important, PTEN mRNA and protein levels were found to be significantly lower in medulloblastomas compared with normal cerebellar tissue of different developmental stages. Reduction of PTEN expression was found to be associated with PTEN promoter hypermethylation in 50% of the tumor samples. Conclusions: We conclude that activation of the PI3K/AKT pathway constitutes an important step in the molecular pathogenesis of medulloblastoma and that dysregulation of PTEN may play a significant role in this context.